相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients
Michele Correale et al.
HEART FAILURE REVIEWS (2023)
Arterial Stiffness in Aging: Does It Have a Place in Clinical Practice? Recent Advances in Hypertension
Gary F. Mitchell
HYPERTENSION (2021)
Vascular Stiffness in Aging and Disease
Stephen F. Vatner et al.
FRONTIERS IN PHYSIOLOGY (2021)
PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target
Rawan Altalhi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Arterial stiffness in health and disease: The role of cardio-ankle vascular index
Toru Miyoshi et al.
JOURNAL OF CARDIOLOGY (2021)
Hypertriglyceridemic Waist in Patients with Type 2 Diabetes: Its Relationship to Selected Markers of Vascular Damage
David Karasek et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2021)
Plasma levels of von Willebrand factor in type 2 diabetes patients with and without cardiovascular diseases: A meta-analysis
Xun Peng et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2020)
Effect of Bariatric Surgery on the Circulating Level of Adiponectin, Chemerin, Plasminogen Activator Inhibitor-1, Leptin, Resistin, and Visfatin: A Systematic Review and Meta-Analysis
Moein Askarpour et al.
HORMONE AND METABOLIC RESEARCH (2020)
Effects of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12-Month Treatment
Ignatios Ikonomidis et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Heterogeneous effect of aging on vasorelaxation responses in large and small arteries
Meredith Luttrell et al.
PHYSIOLOGICAL REPORTS (2020)
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
N. H. Cho et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Differential response of plasma plasminogen activator inhibitor 1 after weight loss surgery in patients with or without type 2 diabetes
Karin E. Mossberg et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2017)
Pulse wave analysis and diabetes mellitus. A systematic review
Jaromira Gajdova et al.
BIOMEDICAL PAPERS-OLOMOUC (2017)
Diabetes and ageing-induced vascular inflammation
Mariam El Assar et al.
JOURNAL OF PHYSIOLOGY-LONDON (2016)
Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies
James Yarmolinsky et al.
SCIENTIFIC REPORTS (2016)
Molecular Mechanisms of Arterial Stiffening
Marina Cecelja et al.
PULSE (2016)
Adipose Tissue-Derived Plasminogen Activator Inhibitor-1 Function and Regulation
Hiroshi Kaji
COMPREHENSIVE PHYSIOLOGY (2016)
Aortic Stiffness as a Surrogate Endpoint to Micro- and Macrovascular Complications in Patients with Type 2 Diabetes
Claudia R. L. Cardoso et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Arterial stiffness in diabetes mellitus
Stuart B. Prenner et al.
ATHEROSCLEROSIS (2015)
Diabetes and Cardiovascular Disease in Older Adults: Current Status and Future Directions
Jeffrey B. Halter et al.
DIABETES (2014)
Plasminogen Activator Inhibitor-1 in Aging
Koji Yamamoto et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2014)
Prothrombotic markers in asymptomatic dyslipidemic subjects
David Karasek et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2011)
Plasminogen Activator Inhibitor-1 (PAI-1): A Key Factor Linking Fibrinolysis and Age-Related Subclinical and Clinical Conditions
Matteo Cesari et al.
CARDIOVASCULAR THERAPEUTICS (2010)
Dissociation of Aortic Pulse Wave Velocity With Risk Factors for Cardiovascular Disease Other Than Hypertension A Systematic Review
Marina Cecelja et al.
HYPERTENSION (2009)
Von Willebrand factor in cardiovascular disease focus on acute coronary syndromes
Alexander O. Spiel et al.
CIRCULATION (2008)
Rasminogen activator inhibitor-1, adipose tissue and insulin resistance
Marie-Christine Alessi et al.
CURRENT OPINION IN LIPIDOLOGY (2007)
Expert consensus document on arterial stiffness: methodological issues and clinical applications
Stephane Laurent et al.
EUROPEAN HEART JOURNAL (2006)
Inverse relationship between plasminogen activator inhibitor-I activity and adiponect in overweight and obese women - Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation
I Mertens et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Von Willebrand factor in plasma and in liver tissue after partial hepatectomy in the rat
Y Baruch et al.
JOURNAL OF HEPATOLOGY (2002)
Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss
A Mavri et al.
DIABETOLOGIA (2001)
Increased plasma levels of endothelin 1 and von Willebrand factor in patients with type 2 diabetes and dyslipidemia
BGS Seligman et al.
DIABETES CARE (2000)
分享论文
